Abstract
Rationale
Understanding atrial fibrillation (AF) requires integrated understanding of ionic currents and Ca2+ transport in remodeled human atrium, but appropriate models are limited.
Objective
To study AF we developed a new human atrial action potential (AP) model, derived from atrial experimental results and our human ventricular myocyte model.
Methods and Results
Atria vs. ventricles have lower IK1, resulting in more depolarized resting membrane potential (~7mV). We used higher Ito,fast density in atrium, removed Ito,slow, and included an atrial-specific IKur. INCX and INaK densities were reduced in atrial vs. ventricular myocytes according to experimental results. SERCA function was altered to reproduce human atrial myocyte Ca2+ transients. To simulate chronic AF, we reduced ICaL, Ito, IKur and SERCA, and increased IK1, IKs and INCX. We also investigated the link between Kv1.5 channelopathy, [Ca2+]i, and AF. The sinus rhythm model showed a typical human atrial AP morphology. Consistent with experiments, the model showed shorter APs and reduced AP duration shortening at increasing pacing frequencies in AF or when ICaL was partially blocked, suggesting a crucial role of Ca2+ and Na+ in this effect. This also explained blunted Ca2+ transient and rate-adaptation of [Ca2+]i and [Na+]i in chronic AF. Moreover, increasing [Na+]i and altered INaK and INCX causes rate-dependent atrial AP shortening. Blocking IKur to mimic Kv1.5 loss-of-function increased [Ca2+]i and caused early-afterdepolarizations under adrenergic stress, as observed experimentally.
Conclusions
Our study provides a novel tool and insights into ionic bases of atrio-ventricular AP differences, and shows how Na+ and Ca2+ homeostasis critically mediate abnormal repolarization in AF.
Keywords: computer model, action potential, Ca2+ cycling, atrial fibrillation
Introduction
Atrial fibrillation (AF) is the most common cardiac arrhythmia observed clinically, and is the main cause of embolic stroke 1. The mechanisms underlying AF remain unclear, and AF is thought to be maintained either via ectopic foci, multiple wavelets, or fibrillatory conduction emanating from a small number of stable rotors 2. Electrical and structural remodeling have emerged as key elements in the development of the AF substrate (e.g., the tendency for persistence of AF)3. Electrical remodeling includes changes in Ca2+ and K+ currents leading to shortening of the action potential (AP) duration (APD) and loss of APD rate-dependent adaptation, whereas structural remodeling leads to changes in atrial myocyte and tissue morphology (e.g. cell hypertrophy, fibrosis) 3-5.
At present mechanisms leading to perpetuation of AF are still undetermined. Growing experimental evidence points to abnormal intracellular Ca2+-handling as a key mediator in AF-pathophysiology 6, 7, but the mechanism through which Ca2+-related abnormalities can lead to the occurrence and maintenance of AF are poorly understood. Models of human atrial myocytes have been developed and used to gain mechanistic insights into human atrial cell physiology and pathophysiology 8-10, however none of these included detailed descriptions of Ca2+ (or Na+) regulatory processes. A recent simulation study incorporated and studied the sub-cellular nature of Ca2+ homeostasis and its relation to human atrial action potentials 11; however the role of Ca2+ in mediating AF was not investigated.
We recently developed a model of the human ventricular myocyte AP and Ca2+ transient (CaT) 12, a major advance over prior human ventricular models in robustly describing excitation-contraction coupling, and the model was extensively validated against a broad range of experimental data.
The aims of the present study were two fold: 1) to derive a new human atrial cell model with detailed Ca2+ handling, by implementing experimentally documented structural and ionic differences in atrial vs. ventricular cells 13 and starting from our recently published model of human ventricular myocytes12; 2) to study how Ca2+ homeostasis is involved in abnormal APs seen in chronic AF (cAF), and AF related to adrenergic stress in patients with Kv1.5 mutations 14. Ionic currents in the ventricular model were modified based on experimental data comparing protein expression and function in atrial vs. ventricular myocytes. Importantly, we utilized new experimental data addressing the poorly understood molecular basis of impaired atrial Ca2+ signaling in cAF to constrain our model parameters.
We validated our model by testing its ability to recapitulate a wide range of physiological behaviors observed in experiments. We next investigated the mechanisms of APD and CaT rate-adaptation in sinus rhythm and cAF, and assessed the effects of blocking the atrial-specific ultrarapid K+ current (IKur) in the absence and presence of β-adrenergic activation, to understand arrhythmogenesis in AF related to Kv1.5 channelopathy and adrenergic stress. Finally, right-to-left gradients in repolarizing currents were also included in the model, since in a number of instances the driving source of the AF (reentry or foci) is located in the left atrium 2.
Methods
Cellular [Ca2+]i and electrophysiological methods are described in the Online Supplement and were used to tune our model and for validation. Table 1 shows key changes made in our new human atrial model vs. our ventricular myocyte model, 12 to account for ionic remodeling in cAF, and to simulate the effects of β-adrenergic and cholinergic stimulation. Further details are in Online Supplement, including formulation of IKur block by AVE0118.
Table 1.
Main changes to our human ventricular model to generate the human atrial model, simulate cAF, and β-adrenergic stimulation.
| Atrial vs. Ventricular | cAF vs. Sinus Rhythm | Adrenergic Stimulation | |
|---|---|---|---|
| Ionic Currents | |||
| INa | Unchanged | -10% peak density 56 | Unchanged |
| INaL | None | Added late component 56 | Unchanged |
| IKs | Unchanged | Increased 2-fold 33 | Enhanced maximal conductance (3 fold) and leftward shift in IV relationship (by 40 mV) 57 |
| IKr | Unchanged | Unchanged | Unchanged |
| IKur | Added | -55% in the RA | Enhanced maximal conductance (3 fold) 58 |
| -45% in the LA 4, 33 | |||
| IK1 | 85% reduction 43 | Upregulated +100% 4, 21 | Unchanged |
| Ito | No Ito,slow | ||
| Ito,fast: activation and inactivation negatively shifted and slower inactivation; larger amplitude 59 | Ito,fast | Unchanged | |
| -80% in the RA | |||
| -45% in the LA4, 33 | |||
|
| |||
| Ca and Na handling | |||
| ICaL | Matched amplitude and kinetics at 37°C from our data and 20 | Current density is reduced by 50% in cAF 4, 17, 18 (and present data) | Increased fraction of available channels (+50%), and channel availability shifted leftward (by 3mV) 57 |
| No changes in voltage dependence of activation and inactivation 19 | |||
| INCX | Atrium<ventricle (-30%)60 | Upregulated in cAF (+40%) 17, 25, 61, 62 | Unchanged |
| kd,act increased by 50% | |||
| SERCA | No changes in maximal pump rate | Reduced maximal pump rate 17 | Forward mode km reduced by 50% 57 |
| Kmf increased 2-fold 17,42, 63 | |||
| RyR | Unchanged | Increased sensitivity for luminal Ca (2-fold) 17, 61 | Sensitivity to [Ca2+]SR enhanced twofold 57 |
| SR Ca2+ leak | Unchanged | Increased by 25% | Unchanged |
| TnI | Unchanged | Unchanged | Affinity for Ca2+ decreased 57 |
| INKA | Atrium<ventricle (-30%)60 | Unchanged 64 | Affinity for [Na+]i increased by 25% 65 |
Model differential equations were implemented in Matlab (Mathworks Inc., Natick, MA, USA) and solved numerically using a variable order solver (ode15s). APDs were obtained after pacing digital cells at indicated frequencies at steady-state. APD was measured as the interval between AP upstroke and 90% repolarization level (APD90).
Results
The baseline alterations to our ventricular cell model resulted in a typical Type-3 human atrial AP morphology15 (Figure 1A, right panel). The higher density of K+ currents that are active in AP phase 1 (early repolarization, Ito+IKur) confers the AP a triangular shape lacking a plateau phase. We have investigated the impact on AP shape of varying Ito and IKur densities, and quantified the changes in the plateau potential, which gets more depolarized as the degree of K+ channel blockade increases (Online Figure I, Online Supplement). AP waveform also feeds back onto ion channel gating determining notable differences in atrial currents. For example, although atrial Ito is almost twice as large in voltage clamp experiments (see Online Figure II), in current clamp conditions it is comparable to ventricular Ito,fast (Figure 1G, right vs. left panel). Maximal velocity of AP upstroke was comparable to that measured in experiments of ~140 V/s (vs. 250 V/s in cAF) 16, and was smaller than in the ventricular cell model (372 V/s in the epicardial cell model paced at 1 Hz 12). In fact, INa is remarkably reduced in atrial vs. ventricular cells (Figure 1C, right vs. left panel) during the AP, due to more inactivated channels (because of slower recovery from inactivation at more depolarized atrial resting membrane potential). Although IKr or IKs were not modified vs. ventricular myocytes, the spiky AP reduced net IKr and IKs (Fig. 1E and F). It is noteworthy that the reduction of INCX from the ventricular model resulted in larger INCX in the atrial model (Fig. 1K). This is presumably because of the short early repolarization in atrium and the slightly larger CaT, both favoring inward INCX. ICaL is similar in atria and ventricle in voltage-clamp conditions, but the AP shape causes ICaL to be much larger in atrial vs. ventricular myocyte model (Fig. 1D). IK1 is smaller in atria, consistent with its lower maximal conductance. INaK is decreased (not as much as its pump rate because the higher [Na+]i, 9.1 in atrium vs. 8.2 mmol/L in ventricle at 1 Hz pacing rate, activates the pump more).
Figure 1.

Steady-state human cardiac AP and major underlying currents and CaT at 1 Hz pacing (A-K) for ventricle (left) and atrium (right). Thicker traces represent currents for which density was increased (in atria vs. ventricle or vice versa) because of altered maximal conductance or pump rate to generate the atrial cell model from the ventricular cell model.
A typical Ca2+ transient is shown in Figure 1B (right panel): at 1 Hz pacing rate, diastolic [Ca2+]i is 207 nmol/L and peaks at 462 nmol/L. Simultaneous ICaL and [Ca2+]i measurements in human atrial myocytes at physiological temperature are shown in Figure 2D-G and compared to simulated traces (Figure 2A-B; 0.5 Hz). Simulated CaT amplitude and rate of CaT decay matched the experimental data (Fig. 2B grey line vs. E, and Fig. 2H-I), as did peak ICaL (-6.47 A/F vs. -6.78±0.36 in experiments, Fig. 2A grey line vs. D). When cAF was simulated, by accounting for ion channel remodeling as illustrated in the methods, ICaL was greatly diminished (Fig. 2A, black vs. grey lines), as shown in experiments (Fig. 2D vs. F) 4, 17, 18. The reduced ICaL could explain the reduced sarcoplasmic reticulum (SR) Ca2+ release and CaT amplitude (Fig. 2B,E,G,H), even if SR Ca2+ content were unaltered. However, the reduced ICaL and SERCA function (rate of twitch [Ca2+]i decline; Fig. 2I) and the elevated SR Ca2+ leak and NCX function (greater INCX for a given [Ca2+]i; Fig. 3A-G) all tend to lower SR Ca2+ content in cAF, which is apparent in the model (but not significantly so in the experiments; Fig. 3H).
Figure 2.

Ca2+ current (A) and transient (B) were simulated for a voltage clamp protocol (A, inset) where membrane potential was stepped to +10 mV for 100 ms after a 100 ms duration ramp to -40mV to inactivate fast INa from a holding potential of -80 mV (pacing at 0.5 Hz). For cAF Ca2+ current amplitude is small compared to sinus rhythm (A, grey vs. black traces), as in experiments at physiological temperature in human atrial cells (D vs. F, protocol in D, inset). This leads to a strong reduction in CaT amplitude (B and H), also observed experimentally (E vs. G, H), which also limits the increase in junctional [Ca2+] (C). Twitch [Ca2+]i decline rate (indicative of SERCA function) is slowed in cAF, in agreement with experiments (I).
Figure 3.

Caffeine-induced CaT and INCX in sinus rhythm (A and C) and cAF (B and D) reveal a smaller SR Ca2+ content in cAF compared to sinus rhythm (H). The slope of NCX current vs. [Ca2+]i during the decaying phase of the caffeine-evoked CaT (E-F) was higher in cAF vs. sinus rhythm (G).
We next tested the response of our model to changes in pacing frequency. Simulated human atrial cell APs under baseline conditions (Fig. 4D) shorten with faster pacing rates (Figure 4J, black circles) as shown in atrial myocytes from patients in normal sinus rhythm (Fig. 4A and 4M, black circles) 19. To illustrate the effect of a reduction in ICaL Van Wagoner et al. 19 recorded APs from the same myocytes at various cycle lengths in the presence of the ICaL blocker nifedipine (10 μM), showing little rate–dependent change in APD (Fig. 4C and 4M, grey open circles). Li and Nattel 20 obtained analogous results. Similarly, simulated APs following 50% ICaL block (Figure 4F) exhibited impaired APD rate-adaptation (Figure 4J, grey open circles). Myocytes from chronic AF patients (Figure 4B) are characterized by shorter APD90 values 16, 19, 21-23, with less variation as a function of cycle length than control (sinus rhythm) myocytes (Figure 4M, squares) 4, 16, 19, 22, 23. Analogously, our cAF model predicts shorter APs than sinus rhythm (solid vs. dashed line in Fig. 4D inset), and reduced adaptation to changes in pacing frequency (Figure 4J, squares). At 4 Hz pacing AP duration alternates (Fig. 4E, and so does [Ca2+]i in Fig. 4H). The sinus rhythm model exhibits this behavior at higher frequency (Fig. 4O at 6 Hz pacing rate).
Figure 4.

APs recorded at different cycle lengths in a control human atrial myocyte (A), in a cell from cAF patient (B), and in the same control myocyte exposed to Ca2+ channel block (10 μmol/L nifedipine, C). 19 Simulated steady-state AP and CaT traces are shown for pacing frequencies 0.5, 1, 2, 3, and 4 Hz, for sinus rhythm (sr, D and G), cAF (E and H), and sr with 50% ICaL block (F and I). Simulated APD90 (J) decreases at increasing pacing frequency in sr, but rate-adaptation is impaired in cAF or with ICaL partially inhibited. Experimental results 19 are also reported (M). Predicted CaT amplitude (K) and [Na+]i (L) increase with frequency in sr cells, in agreement with changes in aequorin signals in human atrial muscle strips (N, grey circles). Frequency-dependence of [Ca2+]i, [Na+]i and force is limited in cAF or when ICaL is partially inhibited (K,L,N). Alternating long and short APs and CaTs (O) are predicted in sr and cAF cells paced at 6 Hz.
The model predicts a positive dependency of CaT amplitude on the pacing rate in sinus rhythm (Figure 4G and K, black circles), which is in agreement with intracellular [Ca2+] measurements via aequorin light signals (Figure 4N, grey circles and dashed line) 24 and twitch force measurements (Figure 4N, open circles and solid line) 24, 25. Positive dependency is impaired when ICaL is partially inhibited (Figure 4F and K, grey open circles) and in cAF (Figure 4E and K, squares). Similarly, atrial myocytes from patients with cAF show impaired contractility (Figure 4N, squares)25. Our model also predicts the increase of intracellular [Na+] with increasing pacing frequency, as shown in Figure 4L (and Online Figure IIIA), which is more limited in cAF and with inhibition of ICaL compared to sinus rhythm (squares and grey open circles vs. black circles).
Figures 5 and Online Figure III show that [Na+]i is critical for APD rate-adaptation. Time courses of APD90 and [Na+]i changes subsequent to an increase in pacing frequency from 0.5 to 1 Hz (Online Figure IIIC) suggest that non steady-state measurements (before [Na+]i slowly reaches steady-state) may give rise to highly variable experimental APD adaptation curves. Moreover, if [Na+]i is clamped in the model, the APD rate adaptation is nearly abolished (Fig. 5A). Simulation of partial block of NKA causes a biphasic APD response (Figure 5D): first, APD prolongation by acute NKA current block, then as [Na+]i rises it increases outward NKA causing APD shortening. Importantly, we validated these model predictions in isolated human atrial myocytes challenged with strophanthidin (10 μmol/L). Acute NKA inhibition was confirmed by abrupt and relatively sustained depolarization of resting membrane potential (Figure 5C). Figure 5C shows a typical time course of APD90 from a representative cell and pooled data (n=10). Strophanthidin application produces an initial marked increase and subsequent decrease in APD90 (Figure 5C, right). Similar behavior has been described in guinea pig ventricular myocytes, 26 human atrial fibers, 27 and rabbit atrial myocytes (not shown).
Figure 5.

A) APD90 decreases with increasing pacing frequency from 0.5 to 2 Hz and [Na+]i changes freely (black circles). If the atrial myocyte is paced at low frequency, but with [Na+]i clamped at 10.5 mmol/L (level predicted at fast rate), APD90 shortens (white circles) to APD90 value at 2 Hz. Similarly, when the atrial myocyte is paced at fast rate and [Na+]i is clamped to the low level predicted with slow pacing, APD90 lengthens (gray circles) to APD90 value at 0.5 Hz. B) NKA and NCX currents at 0.5 and 2 Hz pacing rate. Experimental and simulated time courses of APD90 (C and D), resting membrane potential (C) and [Na+]i (D) following application of strophanthidin (C) and partial (50%) INaK block (D, at time 0) at 0.5 Hz pacing rate. Effect of strophanthidin on mean APD90 (C, right). p<0.05 and **p<0.001 with paired t-test and Bonferroni correction (n = 10 myocytes from 5 patients).
Blockade of the atrial specific current IKur has been proposed to improve atrial contractility without increasing the risk of ventricular arrhythmias. In fact, in human atrial myocardium, block of IKur results in a prolongation and elevation of the AP plateau, which elicit a positive inotropic effect 28, 29. Thus, we assessed the impact of IKur block (modeled as shown in Online Methods and Online Figure IV) on APD and CaT (Figure 6 and Online Figure V). Moderate blockade of IKur (by 25-50%) increases CaT amplitude (Figure 6B) with little effects on APD (Figure 6A) both in sinus rhythm and cAF models, in agreement with experimental results (Figure 6A and B, insets) 28, 29. Enhancement of CaT amplitude is greatly increased when IKur is more fully (75-100%) blocked (Figure 6B), paralleled by AP prolongation (Figure 6A) in agreement with 14 (see also Figure 6D, inset). A more moderate increase in CaT amplitude is also predicted in cAF. In Figure 6C the predicted impact of various degrees of IKur block on sinus rhythm and cAF CaT amplitude (grey symbols and axis) shows good agreement with the reported effect of the IKur inhibitor AVE0118 on contractile force of atrial trabeculae from patients in sinus rhythm and in AF (black symbols and axis) 29.
Figure 6.

Effect of different degrees of IKur block on simulated human atrial APD (A) and CaT (B-C) in sr and cAF is compared with experimental AP recordings 28 (A, inset) and twitch force measurements 29 (B inset and C). D) ISO application causes EADs (green dashed line) in the presence of IKur blockade, as shown experimentally by Olson et al. (D, inset) 14. Blocking IKs does not have the same deleterious effect (red solid line).
To study AF associated with Kv1.5 mutation during β-adrenergic activation, we also investigated the effect of adrenergic stimulation on atrial AP (Figure 6D) by incorporating steady-state effects of PKA-dependent phosphorylation on ICa, IKs, IKur, PLN-SERCA2a, RyR2, troponin Ca2+ affinity and Na/K-ATPase (see Online Supplement). In our simulations, administration of isoproterenol (ISO) causes the CaT amplitude to increase (by ~ 65%, not shown) without major changes in the duration of repolarization (Figure 6D, solid black vs. blue lines), in agreement with data from human atrial preparations 30. When simulating the block of IKur (which is enhanced during adrenergic activation) in the presence of ISO, early after-depolarizations (EADs) occurred (Figure 6D, green dashed line). These results are in agreement with data from Olson et al. 14 (Figure 6D, inset) showing that 4-AP (50 μmol/L) prolonged APD in human atrial myocytes and caused EADs and triggered activity upon ISO (1 μmol/L) challenge. Notably, simulation of IKs (also increased by ISO) blockade (50%) did not affect atrial AP markedly (Figure 6D, red line almost completely overlaps black line).
To reflect parasympathetic effects we also now include an IKACh model (fitted with human data) and demonstrate a dose-dependent reduction in human atrial AP and CaT in response to the parasympathetic transmitter acetylcholine (Online Figure VI). The APD shortening is consistent with experiments in human atria. We did not integrate crosstalk between β-adrenergic and acetylcholine or CaMKII pathways, or develop compartmentalized dynamic G-protein coupled receptor models as done recently for animal myocyte models,31,32 but those would be a logical extensions of our model.
There is only limited data available concerning intra-atrial heterogeneities in repolarizing currents in human atrial myocytes. Caballero et al. found a gradient of IKur with 20% higher density in right atrium (RA) vs. left atrium (LA) 33. We incorporated such heterogeneity to simulate RA and LA APs and CaT (Figure 7A). The slightly higher IKur density in RA has negligible effects on AP and mildly decreases CaT amplitude (Fig. 7A, left; see also Fig. 6). cAF decreases Ito and IKur differentially in right vs. left atrium 33. Indeed, cAF greatly reduced Ito in the RA (~80%) and to a lesser extent in the LA (~45%), thus generating RA-LA Ito gradient. In contrast, IKur was more markedly reduced in the RA (-55%) than in the LA (-45%), thus abolishing the atrial right-to-left IKur gradient observed in sinus rhythm. We simulated these perturbed left-to-right gradients in cAF. IK1 in LA was 2-fold higher in both paroxysmal AF and cAF than in SR, with a left-to-right gradient in paroxysmal AF only 34. Thus, we did not simulate such gradient here. The model predicted a longer AP in the RA during cAF, similar to experimental data 35, with slightly larger CaT amplitude (Figure 7A, right, solid vs. dashed lines), but reduced APD adaptation (Figure 7A, right, solid grey to black vs. dashed grey to black lines). Thus, these changes modify the left-to-right gradients and may contribute to the perpetuation of arrhythmia. To account for variability in AP morphology between and within atria, we also varied K+ and Ca2+ current densities (reduced IKur by 50%, increased ICaL and IKr by 50% and 400% respectively) to produce a Type-1 AP, i.e., similar to the manipulation attempted in an earlier modeling study by Nygren and co-workers. 9 This results in a larger IK and IK/Ito ratio, more depolarized plateau potential, and steeper phase 3 repolarization (Figure 7B, left) as reported by the Nattel group 36 (Figure 7B, right). Importantly, as in experiments,28,37 we show that when IKur is blocked Type-3 AP prolongs (7C, left), whereas Type-1 APD is almost unaltered (7C, right).
Figure 7.

A) Simulated APs and CaTs from right and left atria (RA and LA) at 1Hz and 3 Hz are shown in sinus rhythm (left) and cAF (right). B) Type-1 AP (dashed and bottom panel) was obtained by modifying K+ and Ca2+ current densities in the nominal Type-3 AP (top panel, solid line). C) IKur block prolongs Type-3 APs (left) but has little effect on APD90 of Type-1 APs (right), as shown experimentally (insets) 28, 37. CaTs are shown in bottom panels.
Discussion
We developed a new mathematical model of human atrial myocyte with detailed electrophysiology and Ca2+ handling, including ionic and Ca2+ handling remodeling in cAF. This places our present understanding of atrial myocyte function in a useful quantitative framework to understand how changes in ion channel and Ca2+ handling influence function.
Atrial vs. ventricular cell models
Understanding atrio-ventricular ionic differences is important, has been investigated in simulations and experiments 38, 39, and may lead to safer therapy as a result of targeting atrial-specific ion channels for AF 1, 40. We used the Grandi-Pasqualini-Bers model of the human ventricular AP and CaT 12 as a framework for model development. As a result, the two models have a common format and similar aspects that may be convenient for integrating into whole heart models. Similarities include the Ca2+ handling processes, which is also based on the Shannon-Bers model of the rabbit ventricular myocyte 41. However, appropriate changes to many model parameters were introduced to recapitulate experimental findings in atrial samples from patients in sinus rhythm and cAF. Specific amalgams of ion channel expression and function confers differential AP characteristics for various cardiac regions 42, 43. For example, it is well known that atrial IK1 density is smaller than ventricular IK1, explaining the slightly less negative atrial diastolic membrane potential (by ~5 to 10 mV), reduced Na+ channel availability and slower phase-3 repolarization 43. Again, in humans, IKur is present in atria but not in ventricles 44, and in human atrium, Ito is encoded entirely by Kv4.3 (responsible for Ito,fast) 45, whereas both fast and slow Ito components are detected in human ventricle. We also simulated different AP morphologies and included right-to-left gradients in Ito and IKur as reported recently in human myocytes from the RA and the LA from patients in sinus rhythm or with cAF. This new set of models accounting for tissue-specific ion current differences will be useful for understanding regional electrophysiology, Ca2+ handling and arrhythmia mechanisms.
Novelties of the model compared to previous models
Computational cell modeling has been widely used to understand how individual ionic/molecular components (often studied in isolation) interact in the integrated environment of the cardiac myocyte. For human atrial myocyte models, the Courtemanche 10 and Nygren 9 models, which focused primarily on ion channels generating the atrial AP, have been useful to investigate physiological 46, 47 and pathophysiological 48, 49 mechanisms of the human atrium. However, those models have vastly different properties, especially in their rate-dependent behavior 50. Recently, Maleckar et al. 8 incorporated new experimental K+ current data into the Nygren model, including formulations of IKur and Ito that we have also adopted here. They also studied the early and late phase of atrial repolarization and improved the rate-dependent properties of the AP model.
However, no previous model focused on Ca2+ handling properties of human atrial myocytes, and it is increasingly clear that Ca2+-handling and electrophysiology are intimately linked with respect to arrhythmias7. Cherry et al. 50 showed CaT differences between the two above models, with a more gradual longer lasting transient in the Courtemanche compared to a much sharper CaT in the Nygren/Maleckar models. Our human model uses the Ca2+ handling framework developed by Shannon et al. for rabbit ventricular myocytes 41, which was the first to introduce both a junctional cleft (where ryanodine receptor, RyR, and most ICaL function) and also a subsarcolemmal Ca2+ compartment, where Ca2+-dependent currents (e.g. INCX and ICl(Ca)) sense different local [Ca2+]i compared to bulk [Ca2+]i 51. We have characterized Ca2+ handling properties in atrial myocytes from patients in sinus rhythm and with cAF, and modified the Ca2+ handling parameters in our model accordingly. This recapitulates experimental data including simultaneous measurements of ICaL and CaT, caffeine-induced CaT amplitude (i.e., SR content) and decay time (i.e., SERCA and NCX function) and SR Ca2+ leak at physiological temperature. Our human atrial model provides an accurate representation of Ca2+ homeostasis in human atrial myocytes.
Recently, the Tavi group proposed a model describing heterogeneous subcellular Ca2+ dynamics for human atrial cells presumed to lack of t-tubules.11 They produced a biphasic rise of [Ca2+]i, as seen at 22°C in human atrial myocytes.52 In their model the biphasic [Ca2+]i rise resulted from delay between peripheral and central SR Ca2+ release. An extensive t-tubular network has been reported in atrial myocytes from large mammals.53 Because we did not observe biphasic [Ca2+]i rise in our human atrial myocytes at 37°C (time to peak ~60 ms) and quantitative data on t-tubule organization in human atrial myocytes is lacking, we did not assume slow propagating Ca2+ release toward the cell center.
Rate-dependent APD adaptation
Using our human ventricular myocyte model, we found that the increase in [Na+]i at fast pacing rates feeds back to shorten APD via outward (repolarizing) shifts in Na+/K+ pump (NKA) and NCX currents12. Our human atrial model (Figure 5) and that of the Tavi group11 exhibit analogous behavior. The model showed negligible APD-rate adaptation when [Na+]i was clamped to a certain value (Figure 5A). Notably, we confirmed experimentally in human atrial myocytes the prediction of our model that acutely blocking NKA causes AP prolongation followed by APD shortening (Figure 5C and D), thus supporting the involvement of [Na+]i in APD (via shift in NKA current, Fig. 5B) and rate-dependent APD adaptation in human atrial cells. Furthermore, we show that ICaL block has a similar effect on normal (sinus rhythm) and cAF human atrial action potentials (Figure 4), and in fact similar reductions in APD and APD rate-dependence occur in atrial myocytes isolated from patients with chronic AF. If ICaL is blocked, APD is shorter (less depolarizing current), but also the CaT is greatly diminished, causing less extrusion of Ca2+ and less Na+ entry via NCX. In addition, the positive inotropy observed in normal atrial myocytes is lost in cAF, also limiting NCX-dependent Na+ accumulation at fast rates (as in Fig. 3I). Thus, our model recapitulated experimental results and point to [Na+]i and ICaL as critical components of the normal rate–dependent modulation of atrial APD. While direct effects of [Na+]i on APD are compelling and logical, additional experimental validation of these effect would be valuable. We have discussed previously the role of delayed-rectifier K+ currents in APD rate adaptation 12, and showed in Online Figure VII that IKr block has little effect on APD. Here we ruled out an important role of the atrial-predominant IKur (see Online Figure VIII).
Role of [Ca2+]i in mediating AF in presence of IKur channelopathies
Atrial contractility is decreased in cAF, largely due to electrical remodeling that is associated with downregulation of ICaL 28, 29, which reduces CaT amplitude. Our simulation demonstrated that block of IKur enhances CaT amplitude of human atrial myocytes, both in patients in sinus rhythm or AF (Figure 6), thus pointing to IKur as an atrial-specific target to counteract hypocontractility associated to cAF. Indeed, experiments have shown that IKur blockers in ventricle did not appreciably alter APD or CaT 29.
We hypothesize that IKur in the atrium may serve the same function as IKs in the ventricle, that is opposing AP prolongation expected from larger inward ICaL and INCX during β-adrenergic stress 54. Indeed, our simulations showed that block of IKur (to mimic Kv1.5 mutation that leads to non-functional current, and AF) in the presence of adrenergic challenge causes EADs (Figure 6D). That agrees with experimental data14, where IKur inhibition led to EADs in human atrial myocytes challenged with ISO. On the other hand, IKs block did not appreciably affect APD. Administration of ISO also led to cellular arrhythmic depolarizations when stimulating our model at low pacing frequency (not shown), in accordance with experimental work 14, 55.
Conclusions
We developed a new computational framework to study the contribution of individual ionic pathway differences between atrial and ventricular cells to AP phenotype difference in the human atrium vs. ventricle. It also established that Ca2+ and Na+ handling processes are major contributors to atrial APD and its rate-related behavior in both normal and cAF conditions, and identified the role of IKur in helping prevent EADs in the presence of adrenergic stress. This model (freely available at https://somapp.ucdmc.ucdavis.edu/Pharmacology/bers/) will also be useful for integrating into multicellular models of the human heart.
Supplementary Material
Novelty and Significance.
What is Known?
Atrial cells exhibit electrophysiological characteristics that differ from those of ventricular cells due to structural differences and specific combinations of ion channel/transporters expression and function.
During chronic atrial fibrillation (AF), electrical and structural remodeling contributes to the development of the AF substrate, and abnormalities in intracellular Ca2+ cycling has emerged as key mediators in AF pathophysiology.
Detailed models of myocyte Ca2+ cycling have typically focused on ventricular rather than atrial myocytes, in part because of limited appropriate experimental data (especially from human atrial myocytes).
What New Information Does This Article Contribute?
Based on recent data from human atrial cells, we have developed a new mathematical model of the human atrial myocyte that accounts for the electrophysiological and Ca2+ handling properties of atrial cells in both normal and chronic AF conditions.
Simulations indicate that heart rate-dependent action potential duration (APD) shortening in healthy atrial cells involves the accumulation of intracellular [Na+] at high frequencies that causes outward shifts in Na+/Ca2+ exchange and Na+/K+ pump currents, whereas ionic and Ca2+ handling remodeling lead to reduced Na+ accumulation in chronic AF, which causes a blunted APD rate-dependent response.
Our modeling suggests that IKur is a key component of the adrenergic response of human atrial cells, as its loss (such as in Kv1.5 channelopathy) results in predisposition to early-afterdepolarizations in presence of isoproterenol, and may help explain the bouts of stress mediated AF observed in these patients.
It is increasingly clear that Ca2+-handling and electrophysiology are intimately linked to the development and perpetuation of AF. Thus, understanding AF requires an integrated quantitative understanding of ionic currents and Ca2+ transport in healthy and remodeled human atrium. However, no previous model focused on Ca2+ transport in human atrial myocytes in chronic AF. We developed a new human atrial myocyte model that incorporates the latest experimental data and modern concepts relating to intracellular Ca2+ homeostasis and related electrophysiology, including ionic and Ca2+ handling remodeling seen in chronic AF. Our simulation showed that IKur block enhances the amplitude of the Ca2+ transient of human atrial myocytes, representing an atrial-specific target to counteract hypocontractility associated to cAF. This current is also predicted to oppose APD prolongation expected from larger inward ICaL and INCX during β-adrenergic stress. Our model provides novel insights into the mechanism of APD rate-dependent adaptation, by showing that accumulation of [Na+]i at fast heart rates feeds back to shorten APD via outward shifts in Na+/Ca2+ exchange and Na+/K+ pump currents. This human atrial model provides a useful tool to investigate atrio-ventricular differences with respect to arrhythmogenesis and therapeutical approaches.
Acknowledgments
Authors thank the Heidelberg Cardiosurgeon Team for the provision of human atrial tissue and Claudia Liebetrau and Katrin Kupser for excellent technical assistance. Authors also thank the cardiothoracic surgical team, Golden Jubilee National Hospital, Glasgow, UK, for provision of human atrial tissue.
Sources of Funding NHLBI Grants P01-HL080101 and R37-HL30077 (DMB), P01-HL039707, P01-HL070074 and R01-HL080159 (JJ); AHA Scientist Development Grant (SVP); British Heart Foundation Basic Science Lectureship BS/06/003 (AJW); Fondation Leducq Transatlantic Alliances for Atrial Fibrillation (DD) and CaMKII (DMB).
Non-standard Abbreviations and Acronyms
- AF
Atrial Fibrillation
- AP
Action Potential
- APD
Action Potential Duration
- APD90
Action Potential Duration at 90% repolarization
- cAF
chronic Atrial Fibrillation
- CaT
Ca2+ transient
- EAD
Early After Depolarization
- GNaL
Late Na+ current maximal conductance
- ICaL
L-type Ca2+ current
- ICl(Ca)
Ca2+-activated Cl- current
- IKACh
Acetylcholine-activated K+ current
- IKr
Rapidly activating delayed rectifier K+ current
- IKs
Slowly activating delayed rectifier K+ current
- IKur
Ultrarapid delayed rectifier K+ current
- IK1
Inward rectifier K+ current
- INa
Fast Na+ current
- INCX
Na+/Ca2+ exchange current
- INaK
Na+/K+ pump current
- ISO
Isoproterenol
- Ito
Transient outward K+ current
- LA
Left Atrium
- NCX
Na+/Ca2+ exchange
- NKA
Na+/K+ ATPase
- PKA
Protein Kinase A
- RA
Right Atrium
- RyR
Ryanodine Receptor
- SERCA
Sarcoplasmic Reticulum Ca2+ ATPase
- SK2
Ca2+-activated K+ channels
- sr
sinus rhythm
- SR
Sarcoplasmic Reticulum
Footnotes
Disclosures None.
References
- 1.Benjamin EJ, Chen PS, Bild DE, Mascette AM, Albert CM, Alonso A, Calkins H, Connolly SJ, Curtis AB, Darbar D, Ellinor PT, Go AS, Goldschlager NF, Heckbert SR, Jalife J, Kerr CR, Levy D, Lloyd-Jones DM, Massie BM, Nattel S, Olgin JE, Packer DL, Po SS, Tsang TS, Van Wagoner DR, Waldo AL, Wyse DG. Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop. Circulation. 2009;119(4):606–618. doi: 10.1161/CIRCULATIONAHA.108.825380. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Jalife J. Deja vu in the theories of atrial fibrillation dynamics. Cardiovasc Res. 2011;89(4):766–775. doi: 10.1093/cvr/cvq364. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Nattel S, Burstein B, Dobrev D. Atrial Remodeling and Atrial Fibrillation. Circulation: Arrhythmia and Electrophysiology. 2008;1(1):62–73. doi: 10.1161/CIRCEP.107.754564. [DOI] [PubMed] [Google Scholar]
- 4.Dobrev D, Ravens U. Remodeling of cardiomyocyte ion channels in human atrial fibrillation. Basic Res Cardiol. 2003;98:137–148. doi: 10.1007/s00395-003-0409-8. [DOI] [PubMed] [Google Scholar]
- 5.Workman AJ, Kane KA, Rankin AC. Cellular bases for human atrial fibrillation. Heart Rhythm. 2008;5(6 Suppl):S1–6. doi: 10.1016/j.hrthm.2008.01.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Dobrev D, Nattel S. Calcium Handling Abnormalities in Atrial Fibrillation as a Target for Innovative Therapeutics. Journal of Cardiovascular Pharmacology. 2008;52(4):293–299. doi: 10.1097/FJC.0b013e318171924d. [DOI] [PubMed] [Google Scholar]
- 7.Dobrev D, Voigt N, Wehrens XHT. The ryanodine receptor channel as a molecular motif in atrial fibrillation: pathophysiological and therapeutic implications. Cardiovascular Research. 2011;89(4):734–743. doi: 10.1093/cvr/cvq324. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Maleckar MM, Greenstein JL, Giles WR, Trayanova NA. K+ current changes account for the rate dependence of the action potential in the human atrial myocyte. Am J Physiol Heart Circ Physiol. 2009;297(4):H1398–1410. doi: 10.1152/ajpheart.00411.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Nygren A, Fiset C, Firek L, Clark JW, Lindblad DS, Clark RB, Giles WR. Mathematical Model of an Adult Human Atrial Cell : The Role of K+ Currents in Repolarization. Circ Res. 1998;82(1):63–81. doi: 10.1161/01.res.82.1.63. [DOI] [PubMed] [Google Scholar]
- 10.Courtemanche M, Ramirez RJ, Nattel S. Ionic mechanisms underlying human atrial action potential properties: insights from a mathematical model. Am J Physiol Heart Circ Physiol. 1998;275(1):H301–321. doi: 10.1152/ajpheart.1998.275.1.H301. [DOI] [PubMed] [Google Scholar]
- 11.Koivumaki JT, Korhonen T, Tavi P. Impact of sarcoplasmic reticulum calcium release on calcium dynamics and action potential morphology in human atrial myocytes: a computational study. PLoS Comput Biol. 2011;7(1):e1001067. doi: 10.1371/journal.pcbi.1001067. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Grandi E, Pasqualini FS, Bers DM. A novel computational model of the human ventricular action potential and Ca transient. Journal of Molecular and Cellular Cardiology. 2010;48(1):112–121. doi: 10.1016/j.yjmcc.2009.09.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Hatem SN, Coulombe A, Balse E. Specificities of atrial electrophysiology: Clues to a better understanding of cardiac function and the mechanisms of arrhythmias. J Mol Cell Cardiol. 2010;48(1):90–95. doi: 10.1016/j.yjmcc.2009.08.029. [DOI] [PubMed] [Google Scholar]
- 14.Olson TM, Alekseev AE, Liu XK, Park S, Zingman LV, Bienengraeber M, Sattiraju S, Ballew JD, Jahangir A, Terzic A. Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation. Hum Mol Genet. 2006;15(14):2185–2191. doi: 10.1093/hmg/ddl143. [DOI] [PubMed] [Google Scholar]
- 15.Dawodu AA, Monti F, Iwashiro K, Schiariti M, Chiavarelli R, Puddu PE. The shape of human atrial action potential accounts for different frequency-related changes in vitro. Int J Cardiol. 1996;54(3):237–249. doi: 10.1016/0167-5273(96)02605-8. [DOI] [PubMed] [Google Scholar]
- 16.Workman AJ, Kane KA, Rankin AC. The contribution of ionic currents to changes in refractoriness of human atrial myocytes associated with chronic atrial fibrillation. Cardiovascular Research. 2001;52(2):226–235. doi: 10.1016/s0008-6363(01)00380-7. [DOI] [PubMed] [Google Scholar]
- 17.Voigt N, Trafford AW, Ravens U, Dobrev D. Abstract 2630: Cellular and Molecular Determinants of Altered Atrial Ca2+ Signaling in Patients With Chronic Atrial Fibrillation. Circulation. 2009;120:S667–d-668. 18_MeetingAbstracts. [Google Scholar]
- 18.Christ T, Boknik P, Wohrl S, Wettwer E, Graf EM, Bosch RF, Knaut M, Schmitz W, Ravens U, Dobrev D. L-Type Ca2+ Current Downregulation in Chronic Human Atrial Fibrillation Is Associated With Increased Activity of Protein Phosphatases. Circulation. 2004;110(17):2651–2657. doi: 10.1161/01.CIR.0000145659.80212.6A. [DOI] [PubMed] [Google Scholar]
- 19.Van Wagoner DR, Pond AL, Lamorgese M, Rossie SS, McCarthy PM, Nerbonne JM. Atrial L-Type Ca2+ Currents and Human Atrial Fibrillation. Circ Res. 1999;85(5):428–436. doi: 10.1161/01.res.85.5.428. [DOI] [PubMed] [Google Scholar]
- 20.Li GR, Nattel S. Properties of human atrial ICa at physiological temperatures and relevance to action potential. Am J Physiol Heart Circ Physiol. 1997;272(1):H227–235. doi: 10.1152/ajpheart.1997.272.1.H227. [DOI] [PubMed] [Google Scholar]
- 21.Dobrev D, Graf E, Wettwer E, Himmel HM, Hala O, Doerfel C, Christ T, Schuler S, Ravens U. Molecular Basis of Downregulation of G-Protein-Coupled Inward Rectifying K+ Current (IK,ACh) in Chronic Human Atrial Fibrillation: Decrease in GIRK4 mRNA Correlates With Reduced IK,ACh and Muscarinic Receptor-Mediated Shortening of Action Potentials. Circulation. 2001;104(21):2551–2557. doi: 10.1161/hc4601.099466. [DOI] [PubMed] [Google Scholar]
- 22.Boutjdir M, Le Heuzey J, Lavergne T, Chauvaud S, Guize L, Carpentier A, Peronneau P. Inhomogeneity of cellular refractoriness in human atrium: factor of arrhythmia? Pacing Clin Electrophysiol. 1986;9(6 Pt 2):1095–1100. doi: 10.1111/j.1540-8159.1986.tb06676.x. [DOI] [PubMed] [Google Scholar]
- 23.Bosch RF, Zeng X, Grammer JB, Popovic K, Mewis C, Kuhlkamp V. Ionic mechanisms of electrical remodeling in human atrial fibrillation. Cardiovasc Res. 1999;44(1):121–131. doi: 10.1016/s0008-6363(99)00178-9. [DOI] [PubMed] [Google Scholar]
- 24.Maier LS, Barckhausen P, Weisser J, Aleksic I, Baryalei M, Pieske B. Ca2+ handling in isolated human atrial myocardium. Am J Physiol Heart Circ Physiol. 2000;279(3):H952–958. doi: 10.1152/ajpheart.2000.279.3.H952. [DOI] [PubMed] [Google Scholar]
- 25.Schotten U, Greiser M, Benke D, Buerkel K, Ehrenteidt B, Stellbrink C, Vazquez-Jimenez JF, Schoendube F, Hanrath P, Allessie M. Atrial fibrillation-induced atrial contractile dysfunction: a tachycardiomyopathy of a different sort. Cardiovasc Res. 2002;53(1):192–201. doi: 10.1016/s0008-6363(01)00453-9. [DOI] [PubMed] [Google Scholar]
- 26.Rocchetti M, Besana A, Mostacciuolo G, Ferrari P, Micheletti R, Zaza A. Diverse toxicity associated with cardiac Na+/K+ pump inhibition: evaluation of electrophysiological mechanisms. J Pharmacol Exp Ther. 2003;305(2):765–771. doi: 10.1124/jpet.102.047696. [DOI] [PubMed] [Google Scholar]
- 27.Hordof AJ, Spotnitz A, Mary-Rabine L, Edie RN, Rosen MR. The cellular electrophysiologic effects of digitalis on human atrial fibers. Circulation. 1978;57(2):223–229. doi: 10.1161/01.cir.57.2.223. [DOI] [PubMed] [Google Scholar]
- 28.Wettwer E, Hala O, Christ T, Heubach JF, Dobrev D, Knaut M, Varro A, Ravens U. Role of IKur in controlling action potential shape and contractility in the human atrium: influence of chronic atrial fibrillation. Circulation. 2004;110(16):2299–2306. doi: 10.1161/01.CIR.0000145155.60288.71. [DOI] [PubMed] [Google Scholar]
- 29.Schotten U, de Haan S, Verheule S, Harks EG, Frechen D, Bodewig E, Greiser M, Ram R, Maessen J, Kelm M, Allessie M, Van Wagoner DR. Blockade of atrial-specific K+-currents increases atrial but not ventricular contractility by enhancing reverse mode Na+/Ca2+-exchange. Cardiovasc Res. 2007;73(1):37–47. doi: 10.1016/j.cardiores.2006.11.024. [DOI] [PubMed] [Google Scholar]
- 30.Workman AJ. Cardiac adrenergic control and atrial fibrillation. Naunyn Schmiedebergs Arch Pharmacol. 2010;381(3):235–249. doi: 10.1007/s00210-009-0474-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Soltis AR, Saucerman JJ. Synergy between CaMKII substrates and beta-adrenergic signaling in regulation of cardiac myocyte Ca2+ handling. Biophys J. 2010;99(7):2038–2047. doi: 10.1016/j.bpj.2010.08.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Heijman J, Volders PG, Westra RL, Rudy Y. Local control of beta-adrenergic stimulation: Effects on ventricular myocyte electrophysiology and Ca2+-transient. J Mol Cell Cardiol. 2011;50(5):863–871. doi: 10.1016/j.yjmcc.2011.02.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Caballero R, de la Fuente MG, Gómez R, Barana A, Amorós I, Dolz-Gaitón P, Osuna L, Almendral J, Atienza F, Fernández-Avilés F, Pita A, Rodríguez-Roda J, Pinto Á, Tamargo J, Delpón E. In Humans, Chronic Atrial Fibrillation Decreases the Transient Outward Current and Ultrarapid Component of the Delayed Rectifier Current Differentially on Each Atria and Increases the Slow Component of the Delayed Rectifier Current in Both. Journal of the American College of Cardiology. 2010;55(21):2346–2354. doi: 10.1016/j.jacc.2010.02.028. [DOI] [PubMed] [Google Scholar]
- 34.Voigt N, Trausch A, Knaut M, Matschke K, Varro A, Van Wagoner DR, Nattel S, Ravens U, Dobrev D. Left-to-right atrial inward rectifier potassium current gradients in patients with paroxysmal versus chronic atrial fibrillation. Circ Arrhythm Electrophysiol. 2010;3(5):472–480. doi: 10.1161/CIRCEP.110.954636. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Narayan SM, Kazi D, Krummen DE, Rappel WJ. Repolarization and activation restitution near human pulmonary veins and atrial fibrillation initiation: a mechanism for the initiation of atrial fibrillation by premature beats. J Am Coll Cardiol. 2008;52(15):1222–1230. doi: 10.1016/j.jacc.2008.07.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Wang Z, Fermini B, Nattel S. Delayed rectifier outward current and repolarization in human atrial myocytes. Circ Res. 1993;73(2):276–285. doi: 10.1161/01.res.73.2.276. [DOI] [PubMed] [Google Scholar]
- 37.Firek L, Giles WR. Outward currents underlying repolarization in human atrial myocytes. Cardiovasc Res. 1995;30(1):31–38. [PubMed] [Google Scholar]
- 38.Pandit SV, Berenfeld O, Anumonwo JM, Zaritski RM, Kneller J, Nattel S, Jalife J. Ionic determinants of functional reentry in a 2-D model of human atrial cells during simulated chronic atrial fibrillation. Biophys J. 2005;88(6):3806–3821. doi: 10.1529/biophysj.105.060459. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Pandit SV, Zlochiver S, Filgueiras-Rama D, Mironov S, Yamazaki M, Ennis SR, Noujaim SF, Workman AJ, Berenfeld O, Kalifa J, Jalife J. Targeting atrioventricular differences in ion channel properties for terminating acute atrial fibrillation in pigs. Cardiovasc Res. 2011;89(4):843–851. doi: 10.1093/cvr/cvq359. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Dobrev D, Nattel S. New antiarrhythmic drugs for treatment of atrial fibrillation. The Lancet. 2010;375(9721):1212–1223. doi: 10.1016/S0140-6736(10)60096-7. [DOI] [PubMed] [Google Scholar]
- 41.Shannon TR, Wang F, Puglisi J, Weber C, Bers DM. A Mathematical Treatment of Integrated Ca Dynamics within the Ventricular Myocyte. Biophys J. 2004;87(5):3351–3371. doi: 10.1529/biophysj.104.047449. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Gaborit N, Le Bouter S, Szuts V, Varro A, Escande D, Nattel S, Demolombe S. Regional and tissue specific transcript signatures of ion channel genes in the non-diseased human heart. The Journal of Physiology. 2007;582(2):675–693. doi: 10.1113/jphysiol.2006.126714. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Schram G, Pourrier M, Melnyk P, Nattel S. Differential Distribution of Cardiac Ion Channel Expression as a Basis for Regional Specialization in Electrical Function. Circ Res. 2002;90(9):939–950. doi: 10.1161/01.res.0000018627.89528.6f. [DOI] [PubMed] [Google Scholar]
- 44.Li G-R, Feng J, Yue L, Carrier M, Nattel S. Evidence for Two Components of Delayed Rectifier K+ Current in Human Ventricular Myocytes. Circ Res. 1996;78(4):689–696. doi: 10.1161/01.res.78.4.689. [DOI] [PubMed] [Google Scholar]
- 45.Wang Z, Feng J, Shi H, Pond A, Nerbonne JM, Nattel S. Potential Molecular Basis of Different Physiological Properties of the Transient Outward K+ Current in Rabbit and Human Atrial Myocytes. Circ Res. 1999;84(5):551–561. doi: 10.1161/01.res.84.5.551. [DOI] [PubMed] [Google Scholar]
- 46.Severi S, Corsi C, Cerbai E. From in vivo plasma composition to in vitro cardiac electrophysiology and in silico virtual heart: the extracellular calcium enigma. Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences. 2009;367(1896):2203–2223. doi: 10.1098/rsta.2009.0032. [DOI] [PubMed] [Google Scholar]
- 47.Tsujimae K, Suzuki S, Murakami S, Kurachi Y. Frequency-dependent effects of various IKr blockers on cardiac action potential duration in a human atrial model. American Journal of Physiology - Heart and Circulatory Physiology. 2007;293(1):H660–H669. doi: 10.1152/ajpheart.01083.2006. [DOI] [PubMed] [Google Scholar]
- 48.Zhang H, Garratt CJ, Zhu J, Holden AV. Role of up-regulation of IK1 in action potential shortening associated with atrial fibrillation in humans. Cardiovascular Research. 2005;66(3):493–502. doi: 10.1016/j.cardiores.2005.01.020. [DOI] [PubMed] [Google Scholar]
- 49.Courtemanche M, Ramirez RJ, Nattel S. Ionic targets for drug therapy and atrial fibrillation-induced electrical remodeling: insights from a mathematical model. Cardiovascular Research. 1999;42(2):477–489. doi: 10.1016/s0008-6363(99)00034-6. [DOI] [PubMed] [Google Scholar]
- 50.Cherry EM, Hastings HM, Evans SJ. Dynamics of human atrial cell models: Restitution, memory, and intracellular calcium dynamics in single cells. Progress in Biophysics and Molecular Biology. 2008;98(1):24–37. doi: 10.1016/j.pbiomolbio.2008.05.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Weber CR, Piacentino V, III, Ginsburg KS, Houser SR, Bers DM. Na+-Ca2+ Exchange Current and Submembrane [Ca2+] During the Cardiac Action Potential. Circ Res. 2002;90(2):182–189. doi: 10.1161/hh0202.103940. [DOI] [PubMed] [Google Scholar]
- 52.Hatem SN, Benardeau A, Rucker-Martin C, Marty I, de Chamisso P, Villaz M, Mercadier JJ. Different compartments of sarcoplasmic reticulum participate in the excitation-contraction coupling process in human atrial myocytes. Circ Res. 1997;80(3):345–353. doi: 10.1161/01.res.80.3.345. [DOI] [PubMed] [Google Scholar]
- 53.Lenaerts I, Bito V, Heinzel FR, Driesen RB, Holemans P, D’Hooge J, Heidbuchel H, Sipido KR, Willems R. Ultrastructural and Functional Remodeling of the Coupling Between Ca2+ Influx and Sarcoplasmic Reticulum Ca2+ Release in Right Atrial Myocytes From Experimental Persistent Atrial Fibrillation. Circ Res. 2009;105(9):876–885. doi: 10.1161/CIRCRESAHA.109.206276. [DOI] [PubMed] [Google Scholar]
- 54.Jost N, Virag L, Bitay M, Takacs J, Lengyel C, Biliczki P, Nagy Z, Bogats G, Lathrop DA, Papp JG, Varro A. Restricting excessive cardiac action potential and QT prolongation: a vital role for IKs in human ventricular muscle. Circulation. 2005;112(10):1392–1399. doi: 10.1161/CIRCULATIONAHA.105.550111. [DOI] [PubMed] [Google Scholar]
- 55.Redpath CJ, Rankin AC, Kane KA, Workman AJ. Anti-adrenergic effects of endothelin on human atrial action potentials are potentially anti-arrhythmic. J Mol Cell Cardiol. 2006;40(5):717–724. doi: 10.1016/j.yjmcc.2006.01.012. [DOI] [PubMed] [Google Scholar]
- 56.Sossalla S, Kallmeyer B, Wagner S, Mazur M, Maurer U, Toischer K, Schmitto JD, Seipelt R, Schondube FA, Hasenfuss G, Belardinelli L, Maier LS. Altered Na+ currents in atrial fibrillation effects of ranolazine on arrhythmias and contractility in human atrial myocardium. J Am Coll Cardiol. 2010;55(21):2330–2342. doi: 10.1016/j.jacc.2009.12.055. [DOI] [PubMed] [Google Scholar]
- 57.Shannon TR, Wang F, Bers DM. Regulation of Cardiac Sarcoplasmic Reticulum Ca Release by Luminal [Ca] and Altered Gating Assessed with a Mathematical Model. Biophysical Journal. 2005;89(6):4096–4110. doi: 10.1529/biophysj.105.068734. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Li G-R, Feng J, Wang Z, Fermini B, Nattel S. Adrenergic Modulation of Ultrarapid Delayed Rectifier K+ Current in Human Atrial Myocytes. Circ Res. 1996;78(5):903–915. doi: 10.1161/01.res.78.5.903. [DOI] [PubMed] [Google Scholar]
- 59.Amos GJ, Wettwer E, Metzger F, Li Q, Himmel HM, Ravens U. Differences between outward currents of human atrial and subepicardial ventricular myocytes. The Journal of Physiology. 1996;491(Pt 1):31–50. doi: 10.1113/jphysiol.1996.sp021194. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Wang J, Schwinger RH, Frank K, Müller-Ehmsen J, Martin-Vasallo P, Pressley TA, Xiang A, Erdmann E, McDonough AA. Regional expression of sodium pump subunits isoforms and Na+-Ca2+ exchanger in the human heart. The Journal of Clinical Investigation. 1996;98(7):1650. doi: 10.1172/JCI118960. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Neef S, Dybkova N, Sossalla S, Ort KR, Fluschnik N, Neumann K, Seipelt R, Schondube FA, Hasenfuss G, Maier LS. CaMKII-Dependent Diastolic SR Ca2+ Leak and Elevated Diastolic Ca2+ Levels in Right Atrial Myocardium of Patients With Atrial Fibrillation. Circ Res. 2010;106(6):1134–1144. doi: 10.1161/CIRCRESAHA.109.203836. [DOI] [PubMed] [Google Scholar]
- 62.El-Armouche A, Boknik P, Eschenhagen T, Carrier L, Knaut M, Ravens U, Dobrev D. Molecular determinants of altered Ca2+ handling in human chronic atrial fibrillation. Circulation. 2006;114(7):670–680. doi: 10.1161/CIRCULATIONAHA.106.636845. [DOI] [PubMed] [Google Scholar]
- 63.Boknik P, Unkel C, Kirchhefer U, Kleideiter U, Klein-Wiele O, Knapp J, Linck B, Luss H, Ulrich Muller F, Schmitz W, Vahlensieck U, Zimmermann N, Jones LR, Neumann J. Regional expression of phospholamban in the human heart. Cardiovasc Res. 1999;43(1):67–76. doi: 10.1016/s0008-6363(99)00053-x. [DOI] [PubMed] [Google Scholar]
- 64.Workman AJ, Kane KA, Rankin AC. Characterisation of the Na, K pump current in atrial cells from patients with and without chronic atrial fibrillation. Cardiovasc Res. 2003;59(3):593–602. doi: 10.1016/s0008-6363(03)00466-8. [DOI] [PubMed] [Google Scholar]
- 65.Despa S, Bossuyt J, Han F, Ginsburg KS, Jia L-G, Kutchai H, Tucker AL, Bers DM. Phospholemman-Phosphorylation Mediates the {beta}-Adrenergic Effects on Na/K Pump Function in Cardiac Myocytes. Circ Res. 2005;97(3):252–259. doi: 10.1161/01.RES.0000176532.97731.e5. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
